Itay Tokatly Latzer1,2,3, Liat Lerner-Geva4,5, Daniel Stein6,5, Batia Weiss7,5, Orit Pinhas-Hamiel8,5. 1. Department of Pediatrics A, Tel Aviv University, Tel Aviv, Israel. Itaylatzer@gmail.com. 2. Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Itaylatzer@gmail.com. 3. Department of Pediatrics, Chaim Sheba Medical Center, Derech Sheba 2, 52621, Tel Hashomer, Israel. Itaylatzer@gmail.com. 4. Gertner Institute for Epidemiology and Health Policy Research, Tel Aviv University, Tel Aviv, Israel. 5. Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. 6. Pediatric Psychosomatic Department, Tel Aviv University, Tel Aviv, Israel. 7. Pediatric Gastroenterology Unit, Tel Aviv University, Tel Aviv, Israel. 8. Pediatric Endocrine and Diabetes Unit, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Abstract
PURPOSE: Celiac disease (CD) is a chronic immune-mediated systemic disease characterized by inflammation and villous atrophy of the small intestine. A strict, lifelong gluten-free diet (GFD) is the only treatment for CD. Disordered eating behaviors (DEBs) prevail in adolescence and young adulthood, and confer a risk of developing into full-blown eating disorders. The aims of the current study were to assess the incidence and risk factors for DEBs among individuals with CD, and to examine an association between adherence to GFD and DEBs. METHODS: A cohort of 136 individuals with CD responded to a web-mediated survey that assessed DEBs and adherence to a GFD. The survey included demographic data (gender, age, weight, disease duration) and two self-rating questionnaires: the Eating Attitudes Test-26 and the gluten-free diet questionnaire. RESULTS: DEBs were found in 19% of female and 7% of male responders. These individuals were characterized by being overweight (p = 0.02), of an older age (p = 0.04) and female sex (p = 0.06). Strict adherence to a GFD was reported by 32% of the responders and was not correlated with age, disease duration, age at diagnosis of CD and with being overweight. CONCLUSIONS: Caregivers should be aware of the increased occurrence of DEBs in adolescents with CD, especially those who are overweight, older and of a female gender. LEVEL OF EVIDENCE: Level V, cross-sectional descriptive study.
PURPOSE:Celiac disease (CD) is a chronic immune-mediated systemic disease characterized by inflammation and villous atrophy of the small intestine. A strict, lifelong gluten-free diet (GFD) is the only treatment for CD. Disordered eating behaviors (DEBs) prevail in adolescence and young adulthood, and confer a risk of developing into full-blown eating disorders. The aims of the current study were to assess the incidence and risk factors for DEBs among individuals with CD, and to examine an association between adherence to GFD and DEBs. METHODS: A cohort of 136 individuals with CD responded to a web-mediated survey that assessed DEBs and adherence to a GFD. The survey included demographic data (gender, age, weight, disease duration) and two self-rating questionnaires: the Eating Attitudes Test-26 and the gluten-free diet questionnaire. RESULTS: DEBs were found in 19% of female and 7% of male responders. These individuals were characterized by being overweight (p = 0.02), of an older age (p = 0.04) and female sex (p = 0.06). Strict adherence to a GFD was reported by 32% of the responders and was not correlated with age, disease duration, age at diagnosis of CD and with being overweight. CONCLUSIONS: Caregivers should be aware of the increased occurrence of DEBs in adolescents with CD, especially those who are overweight, older and of a female gender. LEVEL OF EVIDENCE: Level V, cross-sectional descriptive study.
Authors: Miguel Angel Martínez-Olmos; Roberto Peinó; Alma Prieto-Tenreiro; Mary Lage; Laura Nieto; Teresa Lord; Esther Molina-Pérez; Juan Enrique Domínguez-Muñoz; Felipe F Casanueva Journal: Eur Eat Disord Rev Date: 2013-02-07
Authors: Nancy L Young; James W Varni; Laurie Snider; Anna McCormick; Bonita Sawatzky; Marjorie Scott; Gillian King; Ross Hetherington; Ellen Sears; David Nicholas Journal: J Clin Epidemiol Date: 2008-10-01 Impact factor: 6.437
Authors: V Passananti; M Siniscalchi; F Zingone; C Bucci; R Tortora; P Iovino; C Ciacci Journal: Gastroenterol Res Pract Date: 2013-12-04 Impact factor: 2.260
Authors: J W Cadenhead; R L Wolf; B Lebwohl; A R Lee; P Zybert; N R Reilly; J Schebendach; R Satherley; P H R Green Journal: J Hum Nutr Diet Date: 2019-03-05 Impact factor: 3.089